Trials / Completed
CompletedNCT00920296
DDI Study of Etravirine and GSK1265744
A Phase I, Open Label Crossover Study to Evaluate the Effect of Etravirine on GSK1265744 Pharmacokinetics in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to compare steady-state plasma PK, safety and tolerability of GSK1265744 with and without etravirine
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GSK1265744 | GSK drug |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2009-06-15
- Last updated
- 2010-08-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00920296. Inclusion in this directory is not an endorsement.